Chief R&D Officer Greg Friberg Discusses Career | BioMarin

https://investors.biomarin.com/news/news-details/2024/BioMarin-Announces-20-YY-Total-Revenue-Growth-in-the-Second-Quarter-and-Increase-in-Full-year-2024-Guidance/default.aspx

Living with PKU: Jonathan's Story | BioMarin

Living with PKU: Jonathan's Story | BioMarin

https://investors.biomarin.com/news/news-details/2024/BioMarin-Presents-New-Phase-3-Four-Year-Data-Underscoring-Long-Term-Safety-and-Efficacy-of-ROCTAVIAN-valoctocogene-roxaparvovec-rvox-at-International-Society-on-Thrombosis-and-Haemostasis-2024-Congress/default.aspx

https://investors.biomarin.com/news/news-details/2024/New-Data-for-BioMarins-VOXZOGO-vosoritide-for-Multiple-Growth-Related-Conditions-in-Children-Presented-at-Pediatric-Endocrine-Society-PES-Annual-Meeting/default.aspx

https://investors.biomarin.com/news/news-details/2024/BioMarin-Reports-Record-Financial-Results-for-the-First-Quarter-2024/default.aspx

Catching Up with RARE Scholars Program Alumni | BioMarin